Page last updated: 2024-09-03

3,7,12-trihydroxycholestan-26-oic acid and pristanic acid

3,7,12-trihydroxycholestan-26-oic acid has been researched along with pristanic acid in 2 studies

Compound Research Comparison

Studies
(3,7,12-trihydroxycholestan-26-oic acid)
Trials
(3,7,12-trihydroxycholestan-26-oic acid)
Recent Studies (post-2010)
(3,7,12-trihydroxycholestan-26-oic acid)
Studies
(pristanic acid)
Trials
(pristanic acid)
Recent Studies (post-2010) (pristanic acid)
3100103217

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandt, NJ; Christensen, E; Jakobs, C; ten Brink, HJ; Wanders, RJ1
Denis, S; Seedorf, U; van Berkel, E; Wanders, RJ; Wirtz, KW; Wouters, F1

Other Studies

2 other study(ies) available for 3,7,12-trihydroxycholestan-26-oic acid and pristanic acid

ArticleYear
Heterogeneity in di/trihydroxycholestanoic acidaemia.
    Annals of clinical biochemistry, 1994, Volume: 31 ( Pt 2)

    Topics: Cholestanols; Fatty Acids; Humans; Oxidoreductases; Phytanic Acid

1994
Identification of the newly discovered 58 kDa peroxisomal thiolase SCPx as the main thiolase involved in both pristanic acid and trihydroxycholestanoic acid oxidation: implications for peroxisomal beta-oxidation disorders.
    Journal of inherited metabolic disease, 1998, Volume: 21, Issue:3

    Topics: Acetyl-CoA C-Acetyltransferase; Carrier Proteins; Cholestanols; Fatty Acids; Humans; Microbodies; Oxidation-Reduction; Peroxisomal Disorders

1998